RUTLAND, Vt., March 20, 2018 -- Casella Waste Systems, Inc. (Nasdaq:CWST), a regional solid waste, recycling, and resource management services company, announced today that the company’s management will be presenting at the Gabelli 4th Annual Waste & Environmental Services Symposium in New York City on Friday, March 23, 2018 at 10:00 am ET.
The Gabelli Symposium is being held at the Lotte Palace Hotel in New York City. The company indicated that the presentation given at this conference will be made available to all investors on the company’s website. The presentation will be posted prior to the scheduled presentation time, and may be accessed via the Investors’ section of the company’s website at http://ir.casella.com.
For further information, contact Ned Coletta, Chief Financial Officer, at (802) 772-2239, or visit the company’s website at http://www.casella.com.


SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Jetstar to Charge for Overhead Cabin Bags From February
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 



